Hyaluronic acid-based carriers for tumor targeted delivery system / 药学学报
Acta Pharmaceutica Sinica
; (12): 1376-1382, 2013.
Artigo
em Chinês
| WPRIM (Pacífico Ocidental)
| ID: wpr-259466
Biblioteca responsável:
WPRO
ABSTRACT
Hyaluronic acid (HA) as anticancer drug carrier has become the new hot point in the field of tumor-targeted drugs delivery system in recent years. Tumor therapeutic agents could be transmitted into cells because of hyaluronic acid innate ability to recognize specific cellular receptors that overexpressed on tumor cells surface. This review introduces the basic properties and physiology foundation of hyaluronic acid. Recent research developments based on different forms of HA tumor-targeted drugs delivery systems are reviewed in particular.
Texto completo:
Disponível
Base de dados:
WPRIM (Pacífico Ocidental)
Assunto principal:
Portadores de Fármacos
/
Estrutura Molecular
/
Química
/
Sistemas de Liberação de Medicamentos
/
Usos Terapêuticos
/
Tratamento Farmacológico
/
Nanopartículas
/
Ácido Hialurônico
/
Neoplasias
/
Antineoplásicos
Limite:
Animais
/
Humanos
Idioma:
Chinês
Revista:
Acta Pharmaceutica Sinica
Ano de publicação:
2013
Tipo de documento:
Artigo